Literature DB >> 26906521

Effects of Chemically Modified Messenger RNA on Protein Expression.

Bin Li1, Xiao Luo1, Yizhou Dong1.   

Abstract

Chemically modified nucleotides play significant roles in the effectiveness of mRNA translation. Here, we describe the synthesis of two sets of chemically modified mRNAs [encoding firefly Luciferase (FLuc) and enhanced green fluorescent protein (eGFP), respectively], evaluation of protein expression, and correlation analysis of expression level under various conditions. The results indicate that chemical modifications of mRNAs are able to significantly improve protein expression, which is dependent on cell types and coding sequences. Moreover, eGFP mRNAs with N1-methylpseudouridine (me(1)ψ), 5-methoxyuridine (5moU), and pseudouridine (ψ) modifications ranked top three in cell lines tested. Interestingly, 5moU-modified eGFP mRNA was more stable than other eGFP mRNAs. Consequently, me(1)ψ, 5moU, and ψ are promising nucleotides for chemical modification of mRNAs.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26906521     DOI: 10.1021/acs.bioconjchem.6b00090

Source DB:  PubMed          Journal:  Bioconjug Chem        ISSN: 1043-1802            Impact factor:   4.774


  28 in total

Review 1.  Advances in Biomaterials for Drug Delivery.

Authors:  Owen S Fenton; Katy N Olafson; Padmini S Pillai; Michael J Mitchell; Robert Langer
Journal:  Adv Mater       Date:  2018-05-07       Impact factor: 30.849

2.  Design and assessment of engineered CRISPR-Cpf1 and its use for genome editing.

Authors:  Bin Li; Chunxi Zeng; Yizhou Dong
Journal:  Nat Protoc       Date:  2018-04-05       Impact factor: 13.491

Review 3.  Delivering the Messenger: Advances in Technologies for Therapeutic mRNA Delivery.

Authors:  Piotr S Kowalski; Arnab Rudra; Lei Miao; Daniel G Anderson
Journal:  Mol Ther       Date:  2019-02-19       Impact factor: 11.454

Review 4.  Messenger RNA Delivery for Tissue Engineering and Regenerative Medicine Applications.

Authors:  Siddharth Patel; Avathamsa Athirasala; Paula P Menezes; N Ashwanikumar; Ting Zou; Gaurav Sahay; Luiz E Bertassoni
Journal:  Tissue Eng Part A       Date:  2018-06-07       Impact factor: 3.845

5.  mRNA Delivery for Therapeutic Anti-HER2 Antibody Expression In Vivo.

Authors:  Yulia Rybakova; Piotr S Kowalski; Yuxuan Huang; John T Gonzalez; Michael W Heartlein; Frank DeRosa; Derfogail Delcassian; Daniel G Anderson
Journal:  Mol Ther       Date:  2019-05-18       Impact factor: 11.454

6.  Cas13d knockdown of lung protease Ctsl prevents and treats SARS-CoV-2 infection.

Authors:  Zhifen Cui; Cong Zeng; Furong Huang; Fuwen Yuan; Jingyue Yan; Yue Zhao; Yufan Zhou; William Hankey; Victor X Jin; Jiaoti Huang; Herman F Staats; Jeffrey I Everitt; Gregory D Sempowski; Hongyan Wang; Yizhou Dong; Shan-Lu Liu; Qianben Wang
Journal:  Nat Chem Biol       Date:  2022-07-25       Impact factor: 16.174

Review 7.  Nanoscale platforms for messenger RNA delivery.

Authors:  Bin Li; Xinfu Zhang; Yizhou Dong
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2018-05-04

8.  Efficacy and immunogenicity of unmodified and pseudouridine-modified mRNA delivered systemically with lipid nanoparticles in vivo.

Authors:  Kevin J Kauffman; Faryal F Mir; Siddharth Jhunjhunwala; James C Kaczmarek; Juan E Hurtado; Jung H Yang; Matthew J Webber; Piotr S Kowalski; Michael W Heartlein; Frank DeRosa; Daniel G Anderson
Journal:  Biomaterials       Date:  2016-09-25       Impact factor: 12.479

Review 9.  Multifunctional Immunoadjuvants for Use in Minimalist Nucleic Acid Vaccines.

Authors:  Saed Abbasi; Satoshi Uchida
Journal:  Pharmaceutics       Date:  2021-05-01       Impact factor: 6.321

Review 10.  Synthetic modified messenger RNA for therapeutic applications.

Authors:  Minsong Gao; Qingyi Zhang; Xin-Hua Feng; Jianzhao Liu
Journal:  Acta Biomater       Date:  2021-06-13       Impact factor: 8.947

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.